| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/26/2000 | EP1021205A1 Synthesis of ferrocenyl phenyltropane analogs and their radio-transformation to technetium neuroprobes for mapping monoamine reuptake sites |
| 07/26/2000 | EP0643583B1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 07/25/2000 | US6093399 Specific blood coagulation exemplified by in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecific antibody |
| 07/25/2000 | US6093383 Bisamine bisthiol radiolabel binding moieties |
| 07/25/2000 | US6093382 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 07/25/2000 | US6093381 Combining chemotherapeutic agent with lymph node lymphocytes which have been cultured under mitogenic stimulation conditions, or supernatant of it enriched in tumor reactive cells, administering such combination to the cancer patient |
| 07/20/2000 | WO2000041514A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 07/20/2000 | WO2000014537A3 Immunoconjugate for diagnosis of multidrug resistance |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/19/2000 | EP1019102A2 ?32 p-polyphosphazene |
| 07/19/2000 | EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 07/19/2000 | EP0772628B1 Peptide derived radionuclide chelators |
| 07/18/2000 | US6090924 Human-Human CLNH5-specific antibodies |
| 07/18/2000 | US6090563 Growth differentiation factor-6 |
| 07/18/2000 | US6090408 Crosslinked lipids; in situ detection |
| 07/18/2000 | US6090366 Process for the preparation of an organ specific antibodies labeled with technetium-99m |
| 07/18/2000 | US6090365 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040591A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | WO2000040585A1 Cryptate compounds and methods for diagnosis and therapy |
| 07/13/2000 | WO2000040275A2 The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
| 07/13/2000 | WO2000040264A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/13/2000 | WO2000040229A2 Synergistic tumorcidal response induced by histamine |
| 07/13/2000 | CA2358754A1 Synergistic tumorcidal response induced by histamine |
| 07/13/2000 | CA2358570A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | CA2358427A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 07/12/2000 | EP1018343A1 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 07/12/2000 | EP1017817A2 Mutants of thyroid stimulating hormone and methods based thereon |
| 07/12/2000 | EP1017684A1 Contrasting agent for infarct and necrosis imaging |
| 07/12/2000 | EP1017424A1 Lipophilic metal complexes for necrosis and infarct imaging |
| 07/12/2000 | EP1017318A1 Method of imaging cell death in vivo |
| 07/11/2000 | US6087109 Antisense agent which associated with a heat stable toxin receptor; for diagnosis and prevention of intestinal cancers in humans; anticarcinogenic agents . |
| 07/11/2000 | US6086850 Calcitonin receptor binding reagents |
| 07/11/2000 | US6086849 Reagent for preparing a scintigraphic imaging agent, comprising a specific binding peptide having a radiolabel binding moiety that forms a neutral complex when bound to a radioisotope |
| 07/11/2000 | CA2168775C Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes |
| 07/06/2000 | WO2000038681A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine |
| 07/06/2000 | WO2000018331A3 Drug delivery systems |
| 07/06/2000 | CA2357765A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine |
| 07/05/2000 | EP1015884A1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP0853487B1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 07/05/2000 | EP0528891B1 Method for increasing blood-brain barrier permeability |
| 07/04/2000 | US6083966 Thiazoline acid derivatives |
| 07/04/2000 | US6083936 Treatment of estrogen-dependent disorders such as estrogen-dependent cancers; also useful in diagnostic techniques such as magnetic resonance imaging and magnetic resonance spectroscopy |
| 07/04/2000 | US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells |
| 07/04/2000 | US6083481 Radiolabeled reagents that are scintigraphic imaging agents for imaging sites of thrombus formation in vivo |
| 07/04/2000 | US6083480 Calcitonin receptor binding reagents |
| 07/04/2000 | US6083479 Use of tetraazamacrocycle compounds |
| 07/04/2000 | US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952) |
| 07/04/2000 | US6083477 Useful therapeutic reagents for treating leukemias and lymphomas;conjugate of a non-immunogenic rnase or a therapeutic radionuclide that is an alpha-emitter or a beta-emitter and a cell-specific cytokine |
| 06/29/2000 | WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/29/2000 | WO2000009076A8 Imaging with tc-99m labeled fibrin-alpha-chain peptide |
| 06/29/2000 | WO1999055386A3 Stimulus sensitive gel with radioisotope and methods of making |
| 06/29/2000 | WO1998020909A3 Ex-corpore method for treating human blood cells |
| 06/29/2000 | DE19860289A1 Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium New chelators and their tricarbonyl complexes with technetium and rhenium |
| 06/29/2000 | CA2354511A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/28/2000 | EP1013642A2 Chelating agents and the technetium and rhenium tricarbonyl complexes thereof |
| 06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
| 06/28/2000 | EP1012563A1 Breath test for detection of drug metabolism |
| 06/28/2000 | EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 06/28/2000 | EP1012190A1 Eosinophil eotaxin receptor |
| 06/28/2000 | EP1012159A1 Detection and treatment of breast, gynecological and prostate cancer |
| 06/28/2000 | EP1011738A1 Imaging agents for early detection of cardiovascular plaque |
| 06/28/2000 | EP1011737A2 Method for treating proliferative diseases by therapy |
| 06/28/2000 | EP1011654A1 A method of modulating cellular activity |
| 06/28/2000 | EP0915710B1 Stable radioiodine conjugates and methods for their synthesis |
| 06/27/2000 | US6080785 Reacting a alkylnedi-primary amine compound with a protective group such as trifluoroacetyl or benzyl group reagent to form an intermediate, reacting the intermediate with haloacetic tert-bytyl ester to form ester groups, deprotecting |
| 06/27/2000 | US6080777 Taxol as a radiation sensitizer |
| 06/27/2000 | US6080384 Composition made by mixing a stannous salt excluding tin hydroxide with a buffer and organic solvent, admixing with a sulfhydryl-containing biomolecule and lypholizing; mixing the composition with radionuclide to directly bond the isotope |
| 06/27/2000 | US6080383 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |
| 06/22/2000 | WO2000035887A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000004954A3 Novel urokinase inhibitors |
| 06/22/2000 | WO1999061071A3 Assay in vivo of labeled triplex-forming oligonucleotides |
| 06/22/2000 | CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2349501A1 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | CA2349333A1 Vitronectin receptor antagonist pharmaceuticals |
| 06/21/2000 | EP1009726A1 Fluorination of proteins and peptides for f-18 positron emission tomography |
| 06/21/2000 | EP1009447A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 06/21/2000 | EP1009446A1 Imaging methods and compositions |
| 06/20/2000 | US6077499 First conjugate of a tumor targeting moiety, a therapeutic agent, and first member of a binding pair; clearing agent; and second conjugate of the complementary binding member of the binding pair, and second therapeutic agent |
| 06/20/2000 | US6077413 Preparing an implantable medical device having a radioactive metallic surface for use in preventing restenosis in atherosclerotic coronary arteries that have been subjected to percutaneous transluminal coronary angioplasty |
| 06/20/2000 | CA1341035C Macrocyclic polyaza compounds containing 5 or 6 membered rings, process for producing them and pharmaceutical media containing them. |
| 06/15/2000 | WO2000033891A1 Methods for detection of vulnerable plaques using a detectable lipid-avid agent |
| 06/15/2000 | WO2000033874A2 Boron neutron capture therapy using pre-targeting methods |
| 06/15/2000 | WO2000033816A1 Formulation for delivery of particulate material to mucosal membranes |
| 06/15/2000 | WO2000015231A8 Adenosine a3 receptor modulators |
| 06/15/2000 | WO1999066951A3 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 06/14/2000 | EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof |
| 06/14/2000 | EP1007504A1 Sterilized 5-aminolevulinic acid |
| 06/14/2000 | EP1007106A1 Combinatorial library |
| 06/14/2000 | EP1007101A2 Improvements in or relating to diagnostic/therapeutic agents |
| 06/13/2000 | US6075130 Calixarene containing upper rim and a lower rim, atleast one ionizable group attached to lower rim and a radionuclide ion from lantahnide elements bound to ionizable group |
| 06/13/2000 | US6075010 Small molecular weight ligand-hexose containing clearing agents |
| 06/13/2000 | US6074627 Stable complex |
| 06/13/2000 | US6074626 Radioactive cisplatin in the treatment of cancer |
| 06/13/2000 | CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 06/13/2000 | CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates |